Taipei, Taiwan

Teh-Min Hu

This inventor holds 1 USPTO granted patent. Top assignee: National Defense Medical Center. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teh-Min Hu: Innovator in Nitric Oxide Delivery Systems

Introduction

Teh-Min Hu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical technology, particularly in the delivery of therapeutic agents. His innovative work focuses on complex particles designed for delivering nitric oxide, which has important applications in various medical treatments.

Latest Patents

Teh-Min Hu holds a patent for "Complex particles for delivering nitric oxide, method of producing the same, and application of the same." This invention relates to the development of complex particles that can effectively deliver nitric oxide along with additional therapeutic reagents. The patent highlights the method of producing these particles and their potential applications in medical therapies.

Career Highlights

Teh-Min Hu is affiliated with the National Defense Medical Center, where he applies his expertise in medical research and innovation. His work at this institution has allowed him to explore advanced methodologies in drug delivery systems, contributing to the enhancement of therapeutic options available to patients.

Collaborations

Teh-Min Hu collaborates with esteemed colleagues such as Dueng-Yuan Hueng and Jen-Kun Chen. These partnerships foster a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Teh-Min Hu's contributions to nitric oxide delivery systems exemplify the impact of innovative thinking in medical technology. His work not only advances scientific knowledge but also holds promise for improving patient care through enhanced therapeutic methods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…